Trust Company / Wealth Management Firm

Glenview Trust Co — 13F Portfolio

Louisville, KY Kentucky Department of Financial Institutions Regulated Trust Company; SEC Registered Investment Advisor; 13F Filer High Net Worth, Ultra-High Net Worth, Family Office, Institutional Trust & Estate CIK: 0001691827
13F Score ?
32
3Y · Top 10 · Mgr Wt
13F Score ?
37
7Y · Top 10 · Mgr Wt
S&P 500 ?
80
Benchmark
$6.37B
AUM
+8.41%
2026 Q1
+16.11%
1-Year Return
+34.03%
Top 10 Concentration
+5.57%
Turnover
-1.76%
AUM Change
Since 2016
First Filing
500
# of Holdings

Fund Overview

13F Filed: 2026-05-08

As of 2026 Q1, Glenview Trust Co manages $6.37B in reported 13F assets , holds 500 positions with +34.03% top-10 concentration , and delivered a 1-year return of +16.11% on its disclosed equity portfolio. Filing 13F reports since 2016. View full holdings list →

About

Investment Strategy

Analytics Summary

Risk Profile

Key Personnel

John Pence — Chief Executive Officer
Steve Bouchette — Chief Investment Officer
Barry Kornstein — President
Official 13F Filings — SEC EDGAR Key personnel and Fund Overview may contain mistakes

Activity Summary — 2026 Q1

Q1 2026 13F Filed: May 8, 2026

Top Buys

% $
Stock % Impact
+0.23%
+0.22%
+0.21%
+0.21%
+0.19%
+0.19%

Top Sells

% $
Stock % Impact
-0.70%
-0.67%
-0.48%
-0.32%
-0.29%
-0.29%

Top Holdings

2026 Q1 Top 6 mgr. wt. · 2026 Q1+8.41%
Stock %
8.57%
4.39%
ETF
3.14%
3.03%
2.89%
2.72%
View All Holdings

Activity Summary

Latest
Market Value $6.37B
AUM Change -1.76%
New Positions 27
Increased Positions 212
Closed Positions 18
Top 10 Concentration +34.03%
Portfolio Turnover +5.57%
Alt Turnover +6.46%

Sector Allocation Trends

Quarterly History
Free View: Last 10 Quarters. Subscribe to see full history

Holdings Analysis

Size: % of Portfolio Color: Last Full-Quarter Return No data
Free: 10 quarters

Positions Dynamics

Visualizing Top 20 holdings weight history over the last 10 quarters.

Portfolio Analytics — Latest

Glenview Trust Co risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.

Risk access
Building institutional risk profile...
Guru Intelligence Hub Pro
Real-time Analytics
High-Conviction Alpha
AAPL 92.4
NVDA 88.1
MSFT 74.3
Strategy Guardian
Style Drift 0.12
Sector Rotation 0.38

Tracking institutional benchmark deviation

Scenario Lab
2008 GFC -32.4%
Covid-19 -18.1%
2022 Bear -24.7%
Unlock the full Guru Intelligence Hub
Real conviction scores for every holding  ·  Strategy Guardian alerts  ·  Live Scenario Lab stress tests
Upgrade to Pro

Best Strategy vs. Benchmarks

AI Backtest: Auto-Optimizing...
Loading AI Backtest...
Don't be Fooled by Randomness
Access Alpha, Capture Ratios, and Batting Average calibrated for this specific strategy.
UPGRADE NOW
Nassim Taleb — author of Fooled by Randomness
Returns
--
Latest Quarter
--
1-Year Return
--
Ann. Return
Risk
--
Std Deviation
--
Max Drawdown
--
Beta vs SPY
Quality
--
Sharpe
--
Sortino
--
Win Rate
--
Payoff Ratio
Edge Metrics Last 10 quarters only
--
Alpha annualized
--
Up Capture
--
Down Capture

Strategy Backtester: Glenview Trust Co

Replicate top holdings performance • Compare vs benchmarks • Optimize N

Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.

Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.

⏱ Run Backtest

Liquid Glass Edition

0
Backtests Run
+127%
Avg. Return

👆 Click the button to launch tickers!

Don't Be Fooled by Randomness
Proven alpha spans cycles, not just 24 months. Unlock full history since 1999.
PRO ACCESS
Free Demo
Try the Backtester on Real Funds
Run full-history backtests on a curated 2-3 funds. See signal quality, drawdowns, and cycle behavior before you decide.
Underperformance Analysis — Top 10 Holdings vs SPY

Backtesting Glenview Trust Co's top 10 holdings against SPY identified 27 underperformance periods. Worst drawdown: 2020-09 – 2021-03 (-21.1% vs SPY, 7 quarters).

Avg. lag: -4.7% vs SPY Avg. duration: 2.0 quarters
Backtest Snapshot — Top 10 Holdings (Mn-Weighted)

The ticker-level breakdown shows how each of Glenview Trust Co's top holdings contributed to portfolio returns quarter by quarter. Strongest recent contributors inside the last 5 years of the quarterly Top 10 backtest window: NVDA (2021 Q2 – 2025 Q4, +48.1 pts), AAPL (2021 Q2 – 2025 Q4, +11.1 pts), LLY (2022 Q2 – 2025 Q4, +9.2 pts), IVV (2021 Q2 – 2025 Q4, +6.1 pts), MSFT (2021 Q2 – 2025 Q4, +6.0 pts) .

Strategy ann.: 12.4% SPY ann.: 15.2% Period: 2017–2026
Best Recent Contributors — Last 5Y
1 of 5 recent top contributors lagged SPY, which means even some of this fund's best return drivers still failed to beat a simple index over the same window.
2021 Q2 – 2025 Q4 • 19Q in Top 10 Beat SPY
NVDA
+948%
SPY
+76%
Contrib
+48.1%
2021 Q2 – 2025 Q4 • 19Q in Top 10 Beat SPY
AAPL
+103%
SPY
+76%
Contrib
+11.1%
2022 Q2 – 2025 Q4 • 14Q in Top 10 Beat SPY
LLY
+162%
SPY
+83%
Contrib
+9.2%
2021 Q2 – 2025 Q4 • 19Q in Top 10 Beat SPY
IVV
+76%
SPY
+76%
Contrib
+6.1%
2021 Q2 – 2025 Q4 • 19Q in Top 10 Lagged SPY
MSFT
+48%
SPY
+76%
Contrib
+6.0%
Stock return (green = beat SPY)   Stock return (red = lagged SPY)   SPY same period   Cumulative contribution during the last 5 years of the quarterly Mn-weighted Top 10 strategy

Frequently Asked Questions

What does Glenview Trust Co invest in?
Glenview Trust Company's investment strategy is governed by the fiduciary standards of the Uniform Prudent Investor Act (UPIA) and Kentucky trust law — a legal framework that mandates investment decisions be made solely in the interest of beneficiaries, with appropriate attention to risk management, diversification, and the specific objectives and circumstances of each client relationship. Within this fiduciary architecture, the firm pursues a quality-oriented, long-horizon investment approach that seeks to compound client capital through ownership of well-managed businesses with durable competitive advantages, strong free cash flow generation, and disciplined capital allocation. The firm's investment philosophy reflects the influence of institutional-quality fundamental analysis applied within a trust management context — a combination that produces a portfolio orientation distinct from both the passive index-hugging tendencies of large bank trust departments and the high-conviction concentration of boutique hedge fund managers. Glenview Trust's approach occupies the disciplined middle ground: genuinely active security selection based on fundamental research, calibrated within the diversification and risk management imperatives of fiduciary law. This balance produces a portfolio with meaningful active share relative to broad market indices while maintaining the diversification and risk discipline that beneficiary-focused stewardship demands. Sector exposure across Glenview Trust's disclosed 13F holdings reflects the quality-growth orientation of its investment framework, with consistent representation across technology, healthcare, financials, consumer discretionary, and industrials. The firm's preference for businesses with recurring revenue characteristics, pricing power, and strong returns on invested capital produces a natural affinity for the technology and healthcare sectors — industries where intellectual property moats and network effects create the type of durable competitive advantage that long-horizon fiduciary investors seek to own and hold through market cycles. Financial sector exposure reflects both the income characteristics of quality financial institutions and the firm's regional familiarity with banking and insurance businesses in its Kentucky and broader Midwest operating territory. The multi-mandate nature of Glenview Trust's aggregated 13F portfolio — spanning clients with varying risk tolerances, time horizons, income needs, and tax situations — means that disclosed equity holdings represent a composite of customized client allocations rather than a single model portfolio. This characteristic is analytically important: concentration in any individual holding or sector at the aggregate level reflects the cumulative weight of client-level allocations, and the firm's actual investment conviction in specific securities may be more pronounced within individual client portfolios than the aggregate 13F weighting suggests. Analysis of the firm's **Top 10 Holdings Concentration** across quarterly filings provides insight into which securities the firm has consistently favored across its broadest client population — a signal of the firm's highest-conviction, most universally applicable investment ideas. Portfolio turnover within Glenview Trust's equity program is low to moderate, consistent with the long-duration investment horizons of trust and estate clients and the tax efficiency imperatives that are central to fiduciary wealth management. Selling decisions are driven by fundamental thesis changes, valuation excess, or client-specific liquidity needs rather than tactical market timing — producing a portfolio that evolves deliberately and reflects sustained investment conviction in core holdings. The firm's **Sector Allocation History** across 13F filings reveals a quality-growth orientation that has remained philosophically consistent across varying market environments, with tactical adjustments reflecting fundamental opportunities rather than macro-driven repositioning.
What is Glenview Trust Co's AUM?
Glenview Trust Co reported $6.37B in 13F assets as of 2026 Q1. Note: 13F AUM reflects only long equity positions reported to the SEC and may differ from total assets under management.
How concentrated is Glenview Trust Co's portfolio?
Glenview Trust Co holds 500 disclosed positions. The top 10 holdings represent +34.03% of the reported portfolio, indicating a diversified investment approach.
How to track Glenview Trust Co 13F filings?
Track Glenview Trust Co's quarterly filings on SEC EDGAR or on this page — data is updated within days of each filing deadline. Subscribe to 13Foresight for position-change alerts.
Who manages Glenview Trust Co?
Glenview Trust Co is managed by John Pence (Chief Executive Officer), Steve Bouchette (Chief Investment Officer), Barry Kornstein (President).

Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.

Full history →